Susan Hasty, Publisher
Table of Contents . . . January 30th, 2006
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Gene Therapy Week | Other Publications
Cancer Gene Therapy - 5-fluorouracil and gemcitabine enhance gene therapy in pancreatic cancer
Cancer Gene Therapy - Adeno-associated virus serotypes 1 to 5 mediate tumor cell directed gene transfer
Cancer Gene Therapy - Adenoviral-mediated gene therapy elevates activated partial thromboplastin time in prostate cancer
Cancer Gene Therapy - Gene transfer of growth factor receptor suppresses pulmonary metastasis
Cancer Gene Therapy - Oral adeno-associated virus-sTRAIL gene therapy suppresses hepatocellular carcinoma
Antisense Technology - Antisense treatment influences E-cadherin in human gastric carcinoma cells
Cancer Gene Therapy - Novel oncolytic adenovirus targets tumor-associated polo-like kinase 1
Cancer Therapy - Growth factor receptor signaling promotes non-small cell lung cancer tumor survival
Chemotherapy - MDR1 locus displays epigenetic changes in response to chemotherapeutic drugs
DNA Research - Cationic liposomes permit naked plasmid DNA uptake in human macrophages
Gene Therapy - Engineered T lymphocytes resist cytokine withdrawal-induced apoptosis
Hepatocellular Cancer - Conditionally replicative adenovirus vectors facilitate enhanced hepatocellular carcinoma oncolysis
Imaging - Researchers report details of new studies and findings in the area of imaging
Leukemia - PARP-1 down-modulation in leukemia cells restores transcriptional responsiveness
Lung Cancer - Differential CXCR4 expression influences cancer cell metastatic potential
Melanoma - Vascular endothelial growth factor loop promotes melanoma cell invasiveness
Prostate Cancer - Hydrogen peroxide boosts proliferation and migration of prostate cancer cells
Stem Cell Research - Targeting cancer stem cells may inhibit tumor progression and disease recurrence
Stem Cell Research - Two breast stem cell types may be origin for ER alpha-positive and -negative breast tumors
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.